The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain.
The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes [EASD].
In 2013, Silvia Vilares Conde and her research group described that the carotid body, a paired organ that is located in the bifurcation of the common carotid artery and that is classically defined as an oxygen sensor, regulates peripheral insulin sensitivity and that its dysfunction is involved in the development of metabolic diseases.
This first study and others afterwards performed by her group in diabetic rats showed that the bilateral resection of the carotid sinus nerve, and therefore the abolishment of the connection between the carotid body and the brain, restore insulin sensitivity and glucose tolerance. Although efficient this surgical irreversible approach has disadvantages, since the carotid body possess other physiological functions as the response to the lack of oxygen (hypoxia) or the adaptation to exercise. Silvia Conde’s team also described that the carotid body is over-activated in animal models of type 2 diabetes, suggesting that decreasing the activity of the organ could be a good therapeutic strategy.
From the partnership with Galvani Bioelectronics (former Glaxo Smith Kline Bioelectronics), the opportunity to electrically modulate the carotid sinus nerve come up. In fact, this work demonstrated that is possible to maintain glucose homeostasis in animals in which electrodes have been implanted in the carotid sinus nerve and submitted to electrical modulation, without significant adverse effects. It has also been demonstrated that the electrical modulation is reversible. Silvia Conde notes that “this work opens the door to the development of a new therapeutic for type 2 diabetes that will provide a long-term management of the disease with negligible adverse effects and interference with daily activities”.
Type 2 diabetes is characterized by insulin resistance and by increased hepatic glucose production that culminates in hyperglycemia. Although a lot of efforts have been performed until the date none therapeutic induce long-term glycaemia control, being expected for the next decades a huge increase in the prevalence of the disease. Thus, this work gives hope to patients with metabolic diseases, as it brings a new approach for the management of type 2 diabetes.
Learn more: Electronic modulation of carotid sinus nerve can be used as a treatment for type 2 diabetes in rats
The Latest on: Type 2 diabetes
[google_news title=”” keyword=”type 2 diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Harvard Health Publishing And 3 Other Doctors Answer: How Can I Prevent Diabetes?on May 9, 2024 at 8:08 am
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA The best ways to help prevent type 2 diabetes: Maintain a healthy weight, limit ...
- Can yogurt really reduce the risk of Type 2 diabetes? Producers say soon May 9, 2024 at 4:49 am
The US Food and Drug Administration has said it’s OK for producers of yogurt to make the claim that yogurt can reduce the risk of Type 2 diabetes. This is desbite the agency acknowledged that it’s ...
- What Is Type 3 Diabetes?on May 8, 2024 at 5:00 pm
While most of us are familiar with type 1 and type 2 diabetes, you may not have come across the term ‘type 3 diabetes’ before. Jason Kelce reveals the one person he ‘wouldn’t allow’ on stage if he was ...
- Don't Overlook Cardiovascular Risk in Type 1 Diabeteson May 8, 2024 at 7:56 am
Cardiovascular disease management is an often overlooked but critical aspect of care for people with type 1 diabetes, authors of a new review paper said. Cardiovascular disease is the most common ...
- Can yogurt reduce the risk of Type 2 diabetes?on May 6, 2024 at 12:06 pm
Yogurt sold in U.S. grocery store may soon have new labels that say the popular food might help reduce the risk of Type 2 diabetes.
- Can monitoring and encouraging physical activity through phone-based apps improve glycemic control and weight loss in type 2 diabetes patients?on May 6, 2024 at 3:30 am
Whether a smartphone application (app) for maintaining personal health records encouraged physical activity, improved step counts, and glycemic control.
- Ancient grains linked to improved type 2 diabetes outcomeson May 4, 2024 at 7:52 am
A new study suggests ancient grain consumption is associated with improved health outcomes for people with type 2 diabetes. Ancient grains like oats are rich in dietary fiber and phytochemicals that ...
- Ancient Grains Like Oats and Millet Can Help People with Type 2 Diabetes Improve Heart Healthon May 3, 2024 at 6:31 am
A new review showed ancient grains can improve cholesterol levels in people with type 2 diabetes. Aside from incorporating more ancient grains in your diet, experts recommend portion control, and ...
- Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabeteson May 1, 2024 at 4:05 am
Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish Medicines Agency said on ...
- Ancient grains show promise for type 2 diabeteson April 28, 2024 at 11:00 pm
A meta-analysis in the journal Nutrition, Metabolism and Cardiovascular Diseases finds that ancient grains like oats, brown rice, and millet may improve lipid profiles in type 2 diabetes patients, but ...
via Google News and Bing News